Treatment of diffuse alveolar hemorrhage secondary to lupus erythematosus with recombinant activated factor VII administered with a jet nebulizer

Diffuse alveolar hemorrhage (DAH) is a serious pulmonary complication in patients with autoimmune diseases who are undergoing chemotherapy or have had hematopoietic stem cell transplantation. The use of recombinant factor VIIa (rFVIIa) to treat the acute phase of DAH by endobronchial bronchoscopy ha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Intensive Care
Main Authors: Esper, Raúl Carrillo, Estrada, Isis Espinoza de los Monteros, de la Torre León, Teresa, Gutiérrez, Agustín Omar Rosales, López, Jorge Arturo Nava
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4336265/
https://ncbi.nlm.nih.gov/pubmed/25705408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40560-014-0047-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados